Violetta Hughes

CIK: 0001991429

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (16.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

RGEN

REPLIGEN CORP

Officer

AZTA

Azenta, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

RGEN
REPLIGEN CORP
Sep 1, 2026
Tax Payment(F)
Direct
277 shares at avg. $170.02$47K
RGEN
REPLIGEN CORP
Mar 5, 2026
Award(A)
Direct
2.5K shares-
RGEN
REPLIGEN CORP
Sep 2, 2025
Award(A)
Direct
4.1K shares-
AZTA
Azenta, Inc.
Feb 3, 2025
Sale(S)
Direct
317 shares at avg. $52.97$17K
AZTA
Azenta, Inc.
Nov 19, 2024
Sale(S)
Direct
163 shares at avg. $40.07$7K
AZTA
Azenta, Inc.
Nov 15, 2024
Award(A)
Direct
6.9K shares at avg. $41.51$287K

		Type	Shares	Price		Ownership
Sep 1, 2026	RGEN REPLIGEN CORP	Tax Payment(F)	277	$170.02	$47,096	Direct
Mar 5, 2026	RGEN REPLIGEN CORP	Award(A)	2,466	-	$0	Direct
Sep 2, 2025	RGEN REPLIGEN CORP	Award(A)	4,142	-	-	Direct
Feb 3, 2025	AZTA Azenta, Inc.	Sale(S)	317	$52.97	$16,791	Direct
Nov 19, 2024	AZTA Azenta, Inc.	Sale(S)	163	$40.07	$6,531	Direct
Nov 15, 2024	AZTA Azenta, Inc.	Award(A)	6,921	$41.51	$287,291	Direct

1-6 of 6 transactions

About Hughes Violetta

Hughes Violetta (SEC CIK 0001991429) files insider reports with the SEC as CHIEF ACCOUNTING OFFICER of REPLIGEN CORP (RGEN) and VP, Chief Accounting Officer of Azenta, Inc. (AZTA).

Signal8 holds 6 ownership filings by Hughes Violetta (1 Form 3, 5 Form 4), filed between Nov 19, 2024 and Sep 2, 2026. Those filings report 6 transactions, from Nov 15, 2024 to Sep 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Hughes Violetta's filings is in WALTHAM, MA.

Recent filings by Hughes Violetta

Sep 1, 2026: Tax withholding of RGEN shares (Form 4, code F).
Mar 5, 2026: Grant or award of RGEN shares (Form 4, code A).
Sep 2, 2025: Grant or award of RGEN shares (Form 4, code A).
Feb 3, 2025: Open-market sale of AZTA shares (Form 4, code S).
Nov 19, 2024: Open-market sale of AZTA shares (Form 4, code S).

Other insiders filing for REPLIGEN CORP (RGEN)

Douglass Brian Robb, CHIEF PRODUCT OFFICER
Loeillot Olivier, Chief Executive Officer
Garland Jason K, CFO
Madaus Martin D, Director
Konstantinov Konstantin, Director
Mhatre Rohin, Director

How to read Form 4 transaction codes